Download the full-sized PDF of Evaluation of Mesenchymal Stem Cell-Based Therapies for Inflammatory Lung DiseasesDownload the full-sized PDF



Permanent link (DOI):


Export to: EndNote  |  Zotero  |  Mendeley


This file is in the following communities:

Graduate Studies and Research, Faculty of


This file is in the following collections:

Theses and Dissertations

Evaluation of Mesenchymal Stem Cell-Based Therapies for Inflammatory Lung Diseases Open Access


Other title
mesenchymal stem cells
acute lung injury
Type of item
Degree grantor
University of Alberta
Author or creator
Ionescu, Lavinia Iuliana
Supervisor and department
Thébaud, Bernard (Pediatrics, Physiology)
Examining committee member and department
Kassiri, Zamaneh (Physiology)
Cheeseman, Christopher I. (Physiology)
Vliagoftis, Harissios (Medicine)
Roy, Denis-Claude (Medicine, University of Montreal)
Department of Physiology

Date accepted
Graduation date
Doctor of Philosophy
Degree level
Recent discoveries in stem cell biology have generated enthusiasm about the possibility of harnessing stem cells for organ repair and regeneration. The ability of pluri- and multipotent stem cells to differentiate along various cellular lineages has placed them at the core of research that seeks to protect endogenous stem cell populations or to deliver exogenous stem cells to sites of organ injury. Lung diseases are a major health care concern and the prevalence of chronic lung diseases such as asthma, pulmonary fibrosis and chronic obstructive pulmonary disease is expected to continue to rise over the next decades. Meanwhile, improved perinatal care has allowed the survival of extremely premature infants that constitute a particularly vulnerable subpopulation because of their risk of developing bronchopulmonary dysplasia (BPD) with potential life-long complications. Research that aims to evaluate the therapeutic potential of exogenous stem cells in lung diseases placed an initial emphasis on the engraftment and differentiation of these cells in the lung. More recent studies demonstrate that multipotent stem cell populations, such as mesenchymal stromal cells (MSCs), exert paracrine activity that can modulate local inflammatory and immune responses in experimental lung disease models including asthma, acute lung injury (ALI) and pulmonary fibrosis. The studies presented hereby demonstrate that factors secreted by adult bone marrow-derived MSCs can prevent the development of inflammatory lung diseases in mouse models of asthma and ALI and provide mechanistic insight into the anti-inflammatory properties of MSCs. The perspective of using pluripotent stem cells as therapeutic agents has been revived by the landmark discovery of induced pluripotency, where “embryonic stem cell (ESC)-like” cells can be generated by reprogramming terminally differentiated somatic cells. While the field of induced pluripotent stem cell (iPSC) biology is still in its effervescent infancy, this finding may relieve many ESCs-related ethical concerns and may open the way to large-scale production and evaluation of pluripotent stem cells for organ regeneration and repair. The additional study presented provides proof-of-concept for the utility of iPSC. Together, the studies presented hereby advocate the potential of stem cells as a novel clinical option for the treatment of severe lung diseases.
Permission is hereby granted to the University of Alberta Libraries to reproduce single copies of this thesis and to lend or sell such copies for private, scholarly or scientific research purposes only. Where the thesis is converted to, or otherwise made available in digital form, the University of Alberta will advise potential users of the thesis of these terms. The author reserves all other publication and other rights in association with the copyright in the thesis and, except as herein before provided, neither the thesis nor any substantial portion thereof may be printed or otherwise reproduced in any material form whatsoever without the author's prior written permission.
Citation for previous publication
Coltan L, Thébaud B. Chapter 30: Lung. in Regenerative Medicine, Steinhoff, Gustav (Ed.), 1st Edition., 2011. ISBN 978-90-481-9074-4Ionescu LI, Alphonse RS, Arizmendi N, Morgan B, Abel M, Eaton F, Duszyk M, Vliagoftis H, Aprahamian T, Walsh K, Thebaud B. Airway delivery of soluble factors from plastic-adherent bone marrow cells prevents murine asthma. Am J Respir Cell Mol Biol 2012 Feb; 46(2):207-16. Epub 2011 Sep 8

File Details

Date Uploaded
Date Modified
Audit Status
Audits have not yet been run on this file.
File format: pdf (PDF/A)
Mime type: application/pdf
File size: 5242845
Last modified: 2015:10:12 14:30:49-06:00
Filename: Ionescu_Lavinia_Iuliana_Fall2012.pdf
Original checksum: b4f572b3db89fb5a532c04b041bd0911
Activity of users you follow
User Activity Date